International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Hormone Therapy: It's Time for a Second Opinion

Author(s): Collins Joseph J, Ahlgrimm Maria

Issue: Mar/Apr 2008 - Compounding Around the World
View All Articles in Issue

Page(s): 122-127

Hormone Therapy: It's Time for a Second Opinion Page 1

Hormone Therapy: It's Time for a Second Opinion Page 2

Hormone Therapy: It's Time for a Second Opinion Page 3

Hormone Therapy: It's Time for a Second Opinion Page 4

Hormone Therapy: It's Time for a Second Opinion Page 5

Hormone Therapy: It's Time for a Second Opinion Page 6

Download in electronic PDF format for $75

Abstract: The opinion paper titled “Compounded Bioidentical Hormones,” published by the American College of Obstetricians and Gynecologists in November 2005, appears to be aimed at influencing how some clinicians care for their patients. The paper may not accurately report the findings of authors listed in its own references in regard to safety and efficacy of bioidentical hormones, nor does it address the fact that a number of mass-produced preparations on the market include bioidentical estradiol, progesterone, and/or testosterone. The authors of the paper take the point of view that hormone therapy does not belong to a class of drugs with an indication for individualized dosing, but this position is not congruent with the fact that manufacturers of mass-produced hormones have U.S. Food and Drug Administration approval when they discuss flexible dosing of bioidentical hormones. The opinion paper openly opposes compounded bioidentical hormones, yet fails to mention the legal precedence and regulatory oversights that s

Related Keywords: bioidentical hormone replacement therapy, drug safety, US Food and Drug Administration, serum hormone levels, salivary hormone levels, saliva testing, American College of Obstetricians and Gynecologists, ACOG opinion paper, menopause, personalized medicine, estrogen, estradiol, information resources

Related Categories: HRT, LEGAL, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, LITERATURE REVIEW, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Hormone Therapy: It's Time for a Second Opinion Collins Joseph J, Ahlgrimm Maria	Mar/Apr 2008 Pg. 122-127
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Ford Gina, Garcia Lea	Jan/Feb 2001 Pg. 52-54
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing Kells John, Dollbaum Charles M	Sep/Oct 2009 Pg. 392-399
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Gillson George R, Zava David T	Jul/Aug 2003 Pg. 250-256
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J	Sep/Oct 2016 Pg. 359-364
Bioidentical Hormone Replacement Therapy, Part 2, A Review of Wepfer Scott T	Jan/Feb 2002 Pg. 50-54
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Wepfer Scott T	Mar/Apr 2002 Pg. 142-146
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Deleruyelle Laura J	Nov/Dec 2016 Pg. 447-454
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Stephenson Kenna, Jones William, Stephenson Douglas M M	May/Jun 2006 Pg. 175-183
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R	Jul/Aug 2011 Pg. 290-300
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J	Jul/Aug 2004 Pg. 313-319
The Salivary Hormone Profile in the Clinical Evaluation of Women Stephenson Kenna	Nov/Dec 2004 Pg. 427-435
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jan/Feb 2015 Pg. 6-12
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 Deleruyelle Laura J	Jan/Feb 2017 Pg. 6-16
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 DeRosa Angela	Nov/Dec 2020 Pg. 466-470
Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy White Irene Q	Jul/Aug 2005 Pg. 266
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah	Mar/Apr 2010 Pg. 165-170
The Politics of Hormone Replacement Therapy Allen Loyd V Jr	Jul/Aug 2007 Pg. 278-281
The Role of Sex Hormones on Fibromyalgia Pain Mediators Bramwell Bethany L	May/Jun 2010 Pg. 193-199
Return to Top